Journal of diabetes and its complications
-
J. Diabetes Complicat. · Jul 2017
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure.
We investigated the efficacy and safety of dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) and heart failure (HF). ⋯ Dapagliflozin produced clinically meaningful reductions in HbA1c, weight, and SBP in patients with T2DM and HF, and was well tolerated.